Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.36 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.36 |
| ▸ | FAAH | O00519 | 1/20 | 0.34 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.32 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.32 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | CES2 | O00748 | 3/20 | 0.31 |
| ▸ | CES1 | P23141 | 3/20 | 0.31 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.31 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL348782 | 1.00 | TSHR (0.56) | TSHRALDH1A1TP53LMNANFKB1 | |
| SCHEMBL306578 | 1.00 | TSHR (0.56) | TSHRALDH1A1TP53LMNANFKB1 | |
| SCHEMBL347793 | 1.00 | TSHR (0.56) | TSHRALDH1A1TP53LMNANFKB1 | |
| SCHEMBL347023 | 1.00 | TSHR (0.56) | TSHRALDH1A1TP53LMNANFKB1 | |
| SCHEMBL11255873 | 1.00 | TSHR (0.56) | TSHRALDH1A1TP53LMNANFKB1 | |
| SCHEMBL13859605 | 1.00 | TSHR (0.56) | TSHRALDH1A1TP53LMNANFKB1 | |
| SCHEMBL34211 | 1.00 | — | — | |
| SCHEMBL305763 | 1.00 | TSHR (0.56) | TSHRALDH1A1TP53LMNANFKB1 | |
| SCHEMBL349064 | 1.00 | TSHR (0.56) | TSHRALDH1A1TP53LMNANFKB1 | |
| SCHEMBL28244416 | 1.00 | TSHR (0.56) | TSHRALDH1A1TP53LMNANFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117133954-A | Polymer electrolyte membrane based on phosphoric acid doped quaternized polyphenyl ether crosslinked polybenzimidazole and preparation method thereof | 常州大学 | 2023-11-28 | — | — | CN | claimed |
| CN-111187374-B | Luminescent liquid crystal polymer containing menthol chiral structure and preparation method thereof | 湘潭大学 | 2022-02-08 | — | — | CN | claimed |
| CN-113876595-A | Birch alcohol-based quaternary ammonium salt antibacterial organic monomer, application of composite resin of birch alcohol-based quaternary ammonium salt antibacterial organic monomer and preparation method of composite resin of birch alcohol-based quaternary ammonium salt antibacterial organic monomer | 东华大学 | 2022-01-04 | — | — | CN | claimed |
| CN-111187374-A | Luminescent liquid crystal polymer containing menthol chiral structure and preparation method thereof | 湘潭大学 | 2020-05-22 | — | — | CN | claimed |
| WO-2026101900-A1 | NOVEL HYDROXY CYCLOALKYL CONTAINING LIPID COMPOUNDS AND METHODS OF THEIR USE | Acuitas Therapeutics, Inc. (CA) | 2026-05-15 | — | — | WO | disclosed |
| EP-4739652-A1 | LIPIDS AND COMPOSITIONS THEREOF | Kernal Biologics, Inc. (US) | 2026-05-13 | — | — | EP | disclosed |
| US-20260116845-A1 | LIPIDS AND COMPOSITIONS THEREOF | KERNAL BIOLOGICS INC (US) | 2026-04-30 | — | — | US | disclosed |
| EP-4727913-A1 | LIPIDS FOR USE IN LIPID NANOPARTICLES | Acuitas Therapeutics, Inc. (CA) | 2026-04-22 | — | — | EP | disclosed |
| EP-4727915-A1 | AMIDE CONTAINING LIPIDS | Acuitas Therapeutics, Inc. (CA) | 2026-04-22 | — | — | EP | disclosed |
| US-12583816-B2 | Lipids for lipid nanoparticle delivery of active agents | Acuitas Therapeutics, Inc. (CA) | 2026-03-24 | — | — | US | disclosed |
| EP-4705275-A1 | LIPIDS FOR USE IN LIPID NANOPARTICLE FORMULATIONS | Acuitas Therapeutics, Inc. (CA) | 2026-03-11 | — | — | EP | disclosed |
| US-20250188020-A1 | LIPIDS FOR USE IN LIPID NANOPARTICLE FORMULATIONS | ACUITAS THERAPEUTICS INC (CA) | 2025-06-12 | — | — | US | disclosed |
| WO-1993013075-A1 | 1-(ARYLALKYL-AMINOALKYL)IMIDAZOLE DERIVATIVES, PROCESSES OF PREPARATION AND USE AS THERAPEUTICAL AGENTS | THE BOOTS COMPANY PLC (GB) | 1993-07-08 | — | — | WO | disclosed |
| EP-0504660-A2 | Liquid crystal compounds | BASF Aktiengesellschaft (DE) | 1992-09-23 | — | — | EP | disclosed |
| EP-0400848-A2 | Compounds | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1990-12-05 | — | — | EP | disclosed |
| US-4835180-A | N-(ω-cyanoalkyl)aminophenols and use as inhibitors of lipoxygenase activity | STERLING DRUG INC. (US) | 1989-05-30 | — | — | US | disclosed |
| EP-0138504-B1 | STEROID DERIVATIVES | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1988-07-20 | — | — | EP | disclosed |
| EP-0262618-A2 | N-(omega)-cyanoalkyl)aminophenols, and their preparation | STERLING DRUG INC. (US) | 1988-04-06 | — | — | EP | disclosed |
| US-4659516-A | ANTIESTROGENS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1987-04-21 | — | — | US | disclosed |
| EP-0138504-A2 | Steroid derivatives | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1985-04-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250188020-A1 | LIPIDS FOR USE IN LIPID NANOPARTICLE FORMULATIONS | PHOSPHO1, SGMS1, NPC1 | TSHR 2371/4885ALDH1A1 1138/4885TP53 1647/4885 |
| US-12583816-B2 | Lipids for lipid nanoparticle delivery of active agents | NPC1, LDLR, SGMS1 | TSHR 2589/4885ALDH1A1 1473/4885TP53 3226/4885 |
| US-20260116845-A1 | LIPIDS AND COMPOSITIONS THEREOF | LIPC, LIPA, NPC1L1 | TSHR 1603/4885ALDH1A1 2430/4885TP53 3048/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.